AGs Settle Opioid Epidemic-Related Claims Against Amneal Pharmaceuticals for $272.5M
A coalition of AGs reached a settlement in principle with Amneal Pharmaceuticals, Inc., to resolve allegations that it contributed to the opioid epidemic in its role as a drug manufacturer. According to the coalition, Amneal allegedly knowingly failed to monitor and report suspicious orders placed by its customers, as required by federal law. Under the…
